Pay in 4 interest-free payments of $7.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
glp-1 obesity drug news today october 16 2025 gains meet modest dip Flow diagram of GLP-1 Bariatric (<20g net carbs & 5g or less Sugar) Quantity:6 Month Supply
Flow diagram of GLP-1 study selection. | Download Scientific Diagram
In fact, one Greene Street Research analysis cited by Reuters estimated that Pfizer’s $10B bid for Metsera assumed ~$11 billion in revenue for Metsera ’s drugs by 2040, roughly double Metsera’s own forecast ( [34] )
Bariatric (<20g net carbs & 5g or less Sugar)
Quantity:6 Month Supply
The results mark a significant milestone in what is shaping up to be a watershed year for the antiobesity medication pipeline
US$ 24.00
US$ 24.16
US$ 22.44
US$ 22.33
US$ 22.36
US$ 20.24
US$ 21.28
US$ 25.92
US$ 26.31
US$ 26.35
US$ 25.36
US$ 28.20
US$ 24.41